IGLV2-8

Chr 22

immunoglobulin lambda variable 2-8

Also known as: IGLV28, V1-2

Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Jul 2025]

46
ClinVar variants
25
Pathogenic / LP
pLI score
0
Active trials
Clinical SummaryIGLV2-8
📋
ClinVar Variants
25 Pathogenic / Likely Pathogenic· 18 VUS of 46 total submissions

Population Genetics & Constraint

Constraint data not available from gnomAD.

ClinVar Variant Classifications

46 submitted variants in ClinVar

Classification Summary

Pathogenic23
Likely Pathogenic2
VUS18
Likely Benign1
Benign1
Conflicting1
23
Pathogenic
2
Likely Pathogenic
18
VUS
1
Likely Benign
1
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
23
Likely Pathogenic
2
VUS
18
Likely Benign
1
Benign
1
Conflicting
1
Total46

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

IGLV2-8 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype

No OMIM entries found.

Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Top 10 resultsSearch PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →